Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future()

To date, no effective adjuvant treatment for renal cell carcinoma (RCC) has been described, but research in this area is important since the 5-year relapse rate for intermediate- and high-risk early-stage RCC is 30%–40%. Metastatic RCC can be treated successfully with immune therapy and targeted the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Janowitz, Tobias, Welsh, Sarah J., Zaki, Kamarul, Mulders, Peter, Eisen, Tim
Format: Artigo
Sprog:Inglês
Udgivet: W.B. Saunders 2013
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765962/
https://ncbi.nlm.nih.gov/pubmed/23972712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2013.05.004
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker